<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 14 Apr 2026 03:50:32 -0400--><rss version="2.0">
    <channel>
        <title>Sigyn Therapeutics, Inc. (SIGY) SEC Filings</title>
        <link>https://www.sigyntherapeutics.com/investors/sec-filings/annual-reports/rss</link>
        <description>Sigyn Therapeutics, Inc. (SIGY) - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/sigyntherapeutics/files/theme/images/logo-sm.png</url>
                <title>Sigyn Therapeutics, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[NT 10-K - Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT]]></title>
                <description><![CDATA[NT 10-K]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-26-014344/0001493152-26-014344.pdf</link>
                <pubDate>Tue, 31 Mar 26 17:21:34 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-26-014344/0001493152-26-014344.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[3 Related Documents: 10-K, EX-31.1, EX-32.1]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-004740/0001641172-25-004740.pdf</link>
                <pubDate>Tue, 15 Apr 25 13:43:06 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-004740/0001641172-25-004740.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 10-K - Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT]]></title>
                <description><![CDATA[NT 10-K]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-001760/0001641172-25-001760.pdf</link>
                <pubDate>Mon, 31 Mar 25 16:39:29 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-001760/0001641172-25-001760.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-K, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-007240/0001493152-24-007240.pdf</link>
                <pubDate>Tue, 20 Feb 24 16:56:33 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-007240/0001493152-24-007240.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-K, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-23-009883/0001493152-23-009883.pdf</link>
                <pubDate>Fri, 31 Mar 23 06:19:07 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-23-009883/0001493152-23-009883.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-K, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-22-007382/0001493152-22-007382.pdf</link>
                <pubDate>Mon, 21 Mar 22 17:28:54 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-22-007382/0001493152-22-007382.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[3 Related Documents: 10-K, EX-31.1, EX-32.1]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-21-008047/0001493152-21-008047.pdf</link>
                <pubDate>Tue, 06 Apr 21 06:11:42 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-21-008047/0001493152-21-008047.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 10-K - Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT]]></title>
                <description><![CDATA[NT 10-K]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-21-007346/0001493152-21-007346.pdf</link>
                <pubDate>Wed, 31 Mar 21 13:26:13 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-21-007346/0001493152-21-007346.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[4 Related Documents: 10-K, EX-23.1, EX-31.1, EX-32.1]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001753926-20-000068/0001753926-20-000068.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:46:46 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001753926-20-000068/0001753926-20-000068.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[3 Related Documents: 10-K, EX-31.1, EX-32.1]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-19-005117/0001615774-19-005117.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:41:17 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-19-005117/0001615774-19-005117.pdf</guid>
                                                                            </item>
            </channel>
</rss>